Prosecution Insights
Last updated: October 04, 2026

Berg Hill Greenleaf & Ruscitti LLP

Technology area: Biotechnology & Pharmaceuticals

24 pending office actions • 14 clients • 23 examiners • 18 art units • 0 of 24 (0%) have an AI response strategy ready

Analysis

Berg Hill Greenleaf & Ruscitti LLP operates in the Biotechnology & Pharmaceuticals sector, having managed 1018 career applications. The firm has achieved a resolved allowance rate of 84.54 percent, which serves as a key indicator of its success. Currently, there are 21 pending office actions under the firm's management relative to its 1018 career applications.

The firm averages 3.45 office actions per allowance, reflecting a thorough prosecution process that often involves multiple rounds of communication with the patent office. This 3.45 average, combined with the 84.54 percent resolved allowance rate, suggests a persistent approach to securing patent rights. With 1018 career applications, the firm has established a significant presence. The 21 pending office actions and the 3.45 office actions per allowance metric provide a detailed look at the firm's current and historical prosecution performance, offering valuable insights for potential clients and practitioners alike.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1018 apps, methodology: how we score firms)

84.5%
Allowance Rate
n=1018
+0.51σ
Allowance Rate (norm)
n=1018
3.4
OAs to Allowance
n=536
-0.05σ
OAs to Allow (norm)
n=536
1004 days
Time to Allowance
n=536
+15.0pp
Interview Lift
n=1018
27.6%
RCE Rate
n=1018
0.4%
Appeal Rate
n=1018

Rejection Performance (% of received rejections ultimately overcome)

58.8%
§101 Overcome
n=51
65.5%
§102 Overcome
n=252
69.6%
§103 Overcome
n=395
72.9%
§112 Overcome
n=420

Specialization & Scale

A61K, C12N, A01K
Top CPC Subclasses
15%
Top-3 CPC Share
n=1018
2
Practitioners
n=1018
509.0
Apps / Practitioner
n=1018

Portfolio Summary

24
Total Pending OAs
17
Non-Final OAs
5
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

15
Hard (62%)
7
Medium (29%)
2
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (17%)
§103 only2 (8%)
§102 only2 (8%)
§112 only2 (8%)
Double-patenting + other3 (12%)
Multi-statute (no §101)11 (46%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
4% of docket
3
Mechanical / Eng
12% of docket
5
Business / Other
21% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SEAMAN, D MARGARET M 2 76.5% +8.0%
DEVEAU ROSEN, JASON 1 80.1% +16.5%
WEBER, JONATHAN C 1 64.6% +28.5%
HOGE, GARY CHAPMAN 1 63.6% +22.6%
MARVICH, MARIA 1 54.9% +28.1%
NGUYEN, TRUNG Q 1 91.0% +6.2%
SHEN, YANXIN NMN 1 90.0% +22.5%
RILEY, JEZIA 1 82.9% +7.3%
GIOMMI, ALEXANDER PAUL 1 — —
JENNINGS, MICHAEL DEANGILO 1 78.1% +14.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19290958 Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds DEVEAU ROSEN, JASON —

Hard Cases (15)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof SEAMAN, D MARGARET M 60d overdue
17913528 PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF SEGED, NEBYATE SAMUEL 42d overdue
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
17636425 Anti-C7 Antibody Or Antibody Fragment TAYLOR, LIA ELAN 19d
17428581 Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers TSAY, MARSHA M 34d
19020100 ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF HOGE, GARY CHAPMAN —
18865231 SYSTEM AND METHOD FOR MONITORING THE OPERATING CONDITION OF ROTATING ELECTRICAL MACHINERY AND AUTOMATIC DETECTION OF MECHANICAL AND ELECTRICAL FAULTS NGUYEN, TRUNG Q —
18800335 SYNTHESIS OF BACKBONE MODIFIED MORPHOLINO OLIGONUCLEOTIDES AND CHIMERAS USING PHOSPHORAMIDITE CHEMISTRY RILEY, JEZIA —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
19290958 Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds DEVEAU ROSEN, JASON —
19262061 METHOD FOR MANUFACTURING AN AMMUNITION CARTRIDGE AND AMMUNITION CARTRIDGE WEBER, JONATHAN C —
19020100 ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF HOGE, GARY CHAPMAN —
18949090 TARGETED EXTRACELLULAR VESICLES FOR DELIVERY OF THERAPEUTICS MARVICH, MARIA —
18728863 FACADE CLEANING MACHINE JENNINGS, MICHAEL DEANGILO —

Client Portfolio (14 clients)

Top Art Units

Art UnitApps
16622
36411
28581
16291
16631
36511
37231
16131
16551
16531

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19290958 Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds Trait Biosciences, Inc. DEVEAU ROSEN, JASON 1662 §112 Non-Final OA — Pending Aug 05, 2025
19262061 METHOD FOR MANUFACTURING AN AMMUNITION CARTRIDGE AND AMMUNITION CARTRIDGE Serviço Nacional De Aprendizagem Industrial - Departamento Regional Do Rio Grande Do Sul - Senai/Rs WEBER, JONATHAN C 3641 §102 Final Rejection — Pending Jul 07, 2025
19020100 ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF Balloon Innovations, Inc. HOGE, GARY CHAPMAN §102§103 Non-Final OA — Pending Jan 14, 2025
18949090 TARGETED EXTRACELLULAR VESICLES FOR DELIVERY OF THERAPEUTICS Mercury Bio, Inc. MARVICH, MARIA §112DP Non-Final OA — Pending Nov 15, 2024
18865231 SYSTEM AND METHOD FOR MONITORING THE OPERATING CONDITION OF ROTATING ELECTRICAL MACHINERY AND AUTOMATIC DETECTION OF MECHANICAL AND ELECTRICAL FAULTS 2Neuron Solucoes Em Inteligencia Artificial Ltda NGUYEN, TRUNG Q 2858 §101§103§112 Non-Final OA — Pending Nov 12, 2024
18864247 ANTIBIOTIC COMPOSITION AND METHODS OF USE THEREOF The Regents of the University of Colorado SEAMAN, D MARGARET M 1629 §103 Non-Final OA — Pending Nov 08, 2024
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS The Regents of the University of Colorado SHEN, YANXIN NMN 1663 §103§112 Non-Final OA 9d Pending Oct 24, 2024
18800335 SYNTHESIS OF BACKBONE MODIFIED MORPHOLINO OLIGONUCLEOTIDES AND CHIMERAS USING PHOSPHORAMIDITE CHEMISTRY The Regents of the University of Colorado RILEY, JEZIA §102§103§112Other Non-Final OA — Pending Aug 12, 2024
18799172 BALL COLLECTION APPARATUS AND METHODS OF USE THEREOF Buchner Enterprises Inc. Dba Caddie Buddy GIOMMI, ALEXANDER PAUL 3651 §102§103 Non-Final OA — Pending Aug 09, 2024
18728863 FACADE CLEANING MACHINE Melro Corrêa Marcelo De Freitas JENNINGS, MICHAEL DEANGILO 3723 §112 Non-Final OA — Pending Jul 12, 2024
18678152 WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME Trait Biosciences, Inc. FETTEROLF, BRANDON J §102§112 Non-Final OA — Pending May 30, 2024
18603489 1-METHYL-1H-PYRAZOL-3-YL DERIVATIVES FOR USE IN THE TREATMENT OF NEOVASCULAR DISEASES Exonate Limited HUANG, GIGI GEORGIANA 1613 §103DP Non-Final OA 84d Pending Mar 13, 2024
18430133 PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE Trait Biosciences, Inc. KOVALENKO, MYKOLA V 1662 §103§112 Non-Final OA — Pending Feb 01, 2024
18291686 COMPACT CENTRIFUGAL MIXING DEVICE AND METHODS OF USE THEREOF Flacktek Speedmixer, Inc. BHATIA, ANSHU §102§103 Non-Final OA — Pending Jan 24, 2024
18364273 WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY Trait Biosciences, Inc. MOEHLMAN, ANDREW TERRY 1655 §102§103§112DP Non-Final OA — Pending Aug 02, 2023
18183815 METHODS AND COMPOSITIONS FOR THE GENERATION OF PROGRAMABLE POST-TRANSLATIONAL PROTEIN MODIFICATION AND HYDROLYSIS The Regents of the University of California IANNUZO, NATALIE NMN 1653 §103§112 Final Rejection — Pending Mar 14, 2023
18020335 ELECTROCHEMICAL MICROFLUIDIC ASSAY DEVICES Colorado State University Research Foundation MUI, CHRISTINE T 1797 §102 Final Rejection 70d overdue Pending Feb 08, 2023
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof The Regents of the University of Colorado SEAMAN, D MARGARET M 1625 §102§112 Final Rejection 60d overdue Pending Oct 10, 2022
17913528 PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF Colorado State University Research Foundation SEGED, NEBYATE SAMUEL 1758 §103§112 Non-Final OA 42d overdue Pending Sep 22, 2022
17766387 Micron Sized Droplets With Solid Endoskeleton or Exoskeleton Which Tunes The Thermal Stability of The Liquid Droplets The Regents of the University of Colorado STANLEY, JANE L 1767 §102§112 Non-Final OA — Pending Apr 04, 2022
17636425 Anti-C7 Antibody Or Antibody Fragment UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD TAYLOR, LIA ELAN 1641 §101§112 Final Rejection 19d Pending Feb 18, 2022
17603276 Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins Nature'S Toolbox, Inc. SMALL, KATHERINE R 1633 §103 Non-Final OA 77d overdue Pending Oct 12, 2021
17428581 Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers Trait Biosciences, Inc. TSAY, MARSHA M 1656 §101§102§103§112 Non-Final OA 34d Pending Aug 04, 2021
17266502 PARN AS A BIOMARKER AND THERAPEUTIC TARGET The Regents of the University of Colorado TRAN, CHRISTINA L 1637 §101§103§112Other Non-Final OA — Pending Feb 05, 2021

Managing Berg Hill Greenleaf & Ruscitti LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month